Financial Distress and Its Determinants in Rheumatoid Arthritis
Financial distress is prevalent in adults with RA and appears to be greatest in those with comorbidities, specifically depression, identifying a potential area for intervention. Notably, expensive biologic or targeted synthetic disease-modifying antirheumatic drugs were not associated with FACIT-COST scores.
Authors
- Edward Peters (ORCID: https://orcid.org/0000-0003-4928-6532)
- Yunju Im (ORCID: https://orcid.org/0000-0001-7596-3803)
- Kaleb D. Michaud (ORCID: https://orcid.org/0000-0002-5350-3934)
- Ted R. Mikuls (ORCID: https://orcid.org/0000-0002-0897-2272)
- Amber Brown Keebler (ORCID: https://orcid.org/0000-0002-7246-2859)
- Sofia Pedro
Institutions
- Nebraska Medical Center (US)
- The National Databank for Rheumatic Diseases (US)
- VA Nebraska Western Iowa Health Care System (US)
- University of Nebraska Medical Center (US)
Publication Details
- Journal
- Arthritis Care & Research
- Published
- 2025-10-16
- DOI
- https://doi.org/10.1002/acr.25670
- Primary Topic
- Economic and Financial Impacts of Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- U.S. Department of Defense
- Pfizer
- Rheumatology Research Foundation
- Horizon Therapeutics
- National Institutes of Health